11 September 2026
Life-changing motor neurone disease drug to become affordable for Australians

Only around 70 Australians a year are expected to benefit from the PBS listing.
About this report
Downunder Voices provides an independently written summary and community perspective based on information published by the original source. The original publisher remains responsible for its reporting.
Join our community
Follow Downunder Voices
Join thousands of readers following news and community stories from Australia, New Zealand and the Pacific.




